Real-Life Experience with Aflibercept and Ranibizumab in the Treatment of Newly Diagnosed Neovascular Age-Related Macular Degeneration over 24 Months. [electronic resource]
Producer: 20180427Description: 567-572 p. digitalISSN:- 1557-7732
- Aged
- Aged, 80 and over
- Angiogenesis Inhibitors -- therapeutic use
- Female
- Humans
- Intravitreal Injections
- Male
- Middle Aged
- Ranibizumab -- therapeutic use
- Receptors, Vascular Endothelial Growth Factor -- therapeutic use
- Recombinant Fusion Proteins -- therapeutic use
- Retrospective Studies
- Tomography, Optical Coherence
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Visual Acuity
- Wet Macular Degeneration -- diagnosis
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.